Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during May 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec Limited has submitted a routine regulatory disclosure to the exchange regarding shares that were dematerialized (converted from physical certificates into electronic form) during May 2026. This filing is mandated under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, which requires companies to periodically report such conversions. The announcement does not involve any new issuance, buyback, or change in share capital. It is a standard compliance update with no specific financial numbers highlighted in the headline.
This is a routine procedural filing with no material impact on the company's financials, share price, or shareholder value. Shareholders do not need to take any action.